Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-074496
Filing Date
2011-08-08
Accepted
2011-08-08 17:15:50
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c19303e10vq.htm 10-Q 177976
2 EXHIBIT 10.16 c19303exv10w16.htm EX-10.16 212122
3 EXHIBIT 31.1 c19303exv31w1.htm EX-31.1 8538
4 EXHIBIT 32.1 c19303exv32w1.htm EX-32.1 4110
  Complete submission text file 0000950123-11-074496.txt   1353252

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT cpix-20110630.xml EX-101.INS 82342
6 EX-101 SCHEMA DOCUMENT cpix-20110630.xsd EX-101.SCH 9044
7 EX-101 CALCULATION LINKBASE DOCUMENT cpix-20110630_cal.xml EX-101.CAL 29696
8 EX-101 LABELS LINKBASE DOCUMENT cpix-20110630_lab.xml EX-101.LAB 110883
9 EX-101 PRESENTATION LINKBASE DOCUMENT cpix-20110630_pre.xml EX-101.PRE 71514
10 EX-101 DEFINITION LINKBASE DOCUMENT cpix-20110630_def.xml EX-101.DEF 8813
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 111018050
SIC: 2834 Pharmaceutical Preparations